Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M G, Dole"'
Autor:
M G, Dole, M F, Clarke, P, Holman, M, Benedict, J, Lu, R, Jasty, P, Eipers, C B, Thompson, C, Rode, C, Bloch, Nuñez, V P, Castle
Publikováno v:
Cancer research. 56(24)
bcl-x is a member of the bcl-2 family of genes and by alternative splicing gives rise to two distinct mRNAs: bcl-xL and bcl-xS. We have previously investigated the expression of Bcl-x in neuroblastoma (NB) cell lines and have shown that Bcl-xL is exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::054446354abec8dac6aa1e32f32a14bc
https://pubmed.ncbi.nlm.nih.gov/8971184
https://pubmed.ncbi.nlm.nih.gov/8971184
Autor:
B L, Shulkin, D M, Wieland, M E, Baro, D R, Ungar, D S, Mitchell, M G, Dole, J B, Rawwas, V P, Castle, J C, Sisson, R J, Hutchinson
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(1)
The goals of this investigation were to characterize the uptake of 11C-hydroxyephedrine (HED) in neuroblastoma and to determine the feasibility and potential advantages of utilizing this compound as a tumor imaging agent.Seven patients with known or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15dfa9459c9ba9f155058ae8ac9bb352
https://pubmed.ncbi.nlm.nih.gov/8543986
https://pubmed.ncbi.nlm.nih.gov/8543986
Publikováno v:
Cancer research. 55(12)
bcl-x is a new member of the bcl-2 gene family and is highly expressed in neural tissues. The present study was designed to determine the expression of the bcl-x gene products in neuroblastoma (NB) and their role in the modulation of chemotherapy-ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e7f11e158c75c7655e3d9c07606654c
https://pubmed.ncbi.nlm.nih.gov/7780971
https://pubmed.ncbi.nlm.nih.gov/7780971
Autor:
V. R. Pai, Gopal R, Suresh K. Pai, M. G. Dole, Suresh H. Advani, Shripad Banavali, Nadkarni Ks, Giri Nk, Nair Cn, Tapan Saikia, Purna Kurkure, Ravi Patil
Publikováno v:
Journal of Pediatric Hematology/Oncology. 13:109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2b2a5e61fbe690601a3625920acaf81
https://doi.org/10.1097/00043426-199121000-00056
https://doi.org/10.1097/00043426-199121000-00056
Publikováno v:
The Indian Journal of Pediatrics. 56:683-692
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473d9cfe1d7e7477ed93ac670857419d
https://doi.org/10.1007/bf02724450
https://doi.org/10.1007/bf02724450
Publikováno v:
Journal of tropical pediatrics. 35(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8afca7c9605d9827795d28dc2320aa2
https://pubmed.ncbi.nlm.nih.gov/2724402
https://pubmed.ncbi.nlm.nih.gov/2724402
Autor:
S H, Advani, N K, Giri, M G, Dole, S K, Pai, R, Gopal, C N, Nair, A, Das Gupta, T K, Saikia, P A, Kurkure, V R, Pai
Publikováno v:
The Indian journal of medical research. 90
Thirty patients of myelodysplastic syndrome (MDS) were treated over a period of 2 yr using 3 different treatment regimens. Twelve patients received hydroxyurea, 4 were given low dose cytosine arabinoside and 14 others were treated with an aggressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c19ad6fefe6e66fd4b24d2842e65c098
https://pubmed.ncbi.nlm.nih.gov/2620949
https://pubmed.ncbi.nlm.nih.gov/2620949